ARTICLE | Distillery Therapeutics
Cancer
December 13, 2016 7:59 PM UTC
In vitro and cell culture studies identified a HRAS- and KRAS-binding monobody that could help treat cancers driven by HRAS, KRAS or HER2 oncogenes. Screening of a combinatorial monobody library for H...